Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
Novel imaging mass cytometry technology enables a closer look at tumor microenvironment post-pelareorep/atezolizumab/letrozole treatmentAffirms pelareorep's ability to increase PD-L1 positive cells...
Source: marketscreener.com